S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CellectisInhibrxKrystal BiotechAdverum BiotechnologiesAligos Therapeutics
SymbolNASDAQ:CLLSNASDAQ:INBXNASDAQ:KRYSNASDAQ:ADVMNASDAQ:ALGS
Price Information
Current Price$22.16$29.75$84.27$12.15$24.78
52 Week RangeHoldBuyBuyBuyBuy
MarketRank™
Overall Score0.81.51.31.71.3
Analysis Score1.22.52.53.42.5
Community Score2.93.32.52.43.3
Dividend Score0.00.00.00.00.0
Ownership Score0.00.81.72.50.0
Earnings & Valuation Score0.00.60.00.00.6
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$24.25$34.67$101.00$23.50$30.50
% Upside from Price Target9.43% upside16.53% upside19.85% upside93.42% upside23.08% upside
Trade Information
Market Cap$941.49 million$1.12 billion$1.66 billion$1.18 billion$944.56 million
Beta2.59N/A1.21.72N/A
Average Volume443,501174,114169,911837,30681,043
Sales & Book Value
Annual Revenue$22.99 millionN/AN/A$250,000.00N/A
Price / Sales40.95N/AN/A4,737.43N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$8.37 per shareN/A$11.72 per share$2.71 per shareN/A
Price / Book2.65N/AN/A4.48N/A
Profitability
Net Income$-102,090,000.00N/A$-19,090,000.00$-64,490,000.00N/A
EPS($2.41)N/A($1.20)($1.01)N/A
Trailing P/E RatioN/A0.00N/AN/A0.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-110.52%N/AN/AN/AN/A
Return on Equity (ROE)-23.56%N/A-10.72%-32.23%N/A
Return on Assets (ROA)-16.69%N/A-10.40%-28.02%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.10%0.18%N/AN/AN/A
Current Ratio6.11%3.80%39.96%28.53%N/A
Quick Ratio6.00%3.80%39.96%28.53%N/A
Ownership Information
Institutional Ownership Percentage33.30%36.63%73.05%97.41%N/A
Insider Ownership Percentage16.41%N/A27.40%12.40%N/A
Miscellaneous
Employees253755111473
Shares Outstanding42.49 million37.71 million19.71 million97.48 million38.12 million
Next Earnings Date3/4/2021 (Confirmed)3/5/2021 (Estimated)5/3/2021 (Estimated)5/27/2021 (Estimated)N/A
OptionableOptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.